Procurement Summary
Country : USA
Summary : Clinical Research Sites for the Network of Excellence in Neuroscience Clinical Trials (Neuronext Sites) (U24 Clinical Trial not Allowed)
Deadline : 21 Nov 2022
Other Information
Notice Type : Tender
TOT Ref.No.: 71988616
Document Ref. No. : RFA-NS-22-031
Competition : ICB
Financier : Self Financed
Purchaser Ownership : Public
Tender Value : Refer Document
Purchaser's Detail
Name :Login to see tender_details
Address : Login to see tender_details
Email : Login to see tender_details
Login to see detailsTender Details
Tender are invited for Clinical Research Sites for the Network of Excellence in Neuroscience Clinical Trials (NeuroNExT sites) (U24 Clinical Trial Not Allowed)
CFDA Number : 93.853 -- Extramural Research Programs in the Neurosciences and Neurological Disorders
Cost Sharing or Matching Requirement : No
Closing Date for Applications: Nov 21, 2022
Posted Date : Sep 20, 2022
Description: The purpose of this funding opportunity announcement (FOA), issued by NINDS, is to invite currently awarded NeuroNExT sites and potential new sites to participate as a Clinical Site in the Network for Excellence in Neuroscience Clinical Trials (NeuroNExT). This clinical research network develops and conducts multiple, scientifically sound, possibly biomarker-informed exploratory clinical trials evaluating the most promising therapies for neurological disorders, whether from academic, foundation or industry discoveries. Examples include Phase 2 clinical trials and clinical research studies aimed at validating biomarkers and clinical outcomes in preparation for clinical trials. The network provides a robust, standardized, and accessible infrastructure to facilitate rapid development and implementation of protocols in neurological disorders affecting adult and/or pediatric populations. While the network is not specific to one disease, it has the capacity to coordinate a cadre of specialist investigators to implement studies efficiently in respo...
Documents
Tender Notice